THER (Theralink Technologies) FCF Margin %: -1,146.43% (As of Dec. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Theralink Technologies FCF Margin %?

Theralink Technologies THER -99.00% FCF Margin % is -1,146.43% as of Dec. 2023.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Theralink Technologies's Free Cash Flow for the three months ended in Dec. 2023 was $-0.96 Mil. Theralink Technologies's Revenue for the three months ended in Dec. 2023 was $0.08 Mil. Therefore, Theralink Technologies's FCF Margin % for the quarter that ended in Dec. 2023 was -1,146.43%.

As of today, Theralink Technologies's current FCF Yield % is 0.00%.

The historical rank and industry rank for Theralink Technologies's FCF Margin % or its related term are showing as below:

THER' s FCF Margin % Range Over the Past 10 Years
Min: -781.42   Med: 0   Max: 0
Current: -781.42

THER's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -79.91 vs THER: -781.42

Theralink Technologies FCF Margin % Related Terms

Theralink Technologies FCF Margin % Historical Data

* Premium members only.

The historical data trend for Theralink Technologies's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theralink Technologies FCF Margin % Chart

Theralink Technologies Annual Data
Trend Feb14 Feb15 Dec16 Dec17 Dec18 Dec19 Sep20 Sep21 Sep22 Sep23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -2,211.60 -971.74 -972.18 -978.25

Theralink Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,243.64 -1,024.71 -372.77 -840.22 -1,146.43

THER vs AXIM, ISCO, RMTG: FCF Margin % Comparison

For the Biotechnology subindustry, Theralink Technologies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Theralink Technologies FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Theralink Technologies's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Theralink Technologies's FCF Margin % falls into.


Theralink Technologies FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Theralink Technologies's FCF Margin for the fiscal year that ended in Sep. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Sep. 2023 )/Revenue (A: Sep. 2023 )
=-5.938/0.607
=-978.25 %

Theralink Technologies's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-0.963/0.084
=-1,146.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -1,146.43% mean?
Theralink Technologies (THER) has a FCF Margin % of -1,146.43% as of Dec. 2023. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Theralink Technologies and its competitors.
Is Theralink Technologies' FCF Margin % too high?
Theralink Technologies' current FCF Margin % is -1,146.43%.
How does Theralink Technologies' FCF Margin % compare to AXIM and ISCO?
Theralink Technologies' FCF Margin % of -1,146.43% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Theralink Technologies and its competitors. Theralink Technologies's current FCF Margin % is -1,146.43%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Theralink Technologies stock overvalued right now?
Theralink Technologies (THER) has a current FCF Margin % of -1,146.43%. The current FCF Margin % is -1,146.43%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Theralink Technologies (THER), the current FCF Margin % is -1,146.43% as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Theralink Technologies Business Description

Address 15000 West 6th Avenue, Suite 400, Golden, CO, USA, 80401
Theralink Technologies Inc is a proteomics-based, precision medicine and molecular profiling company that specializes in patented Reverse Phase Protein Array (RPPA) and protein biomarker assay services that target multiple areas of oncology. The company provides precision oncology data through its Theralink Reverse Phase Protein Array (RPPA) assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to both FDA-approved and investigational drug treatments. The firm is currently generating revenue with its multiple biopharma contracts and by testing breast cancer patients with its patented Theralink assay.